...
机译:阿托伐他汀被添加到干扰素β中以复发多发性硬化:一项随机对照试验
University Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Freiburgstrasse, 3010, Bern, Switzerland;
Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland;
University Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Freiburgstrasse, 3010, Bern, Switzerland;
University Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Freiburgstrasse, 3010, Bern, Switzerland;
Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland;
Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland;
Department of Neurology, Cantonal Hospital Aarau, Aarau, Switz;
Multiple sclerosis; Atorvastatin; Interferon beta; Randomized clinical trial;
机译:阿托伐他汀被添加到干扰素β中以复发多发性硬化:一项随机对照试验
机译:干扰素β-1a在复发/缓解多发性硬化症中的随机双盲安慰剂对照研究。 PRISMS(通过干扰素β-1a皮下预防多发性硬化症复发和残疾)研究组(请参阅评论)
机译:Peginterferon beta-1a改善了MRI测量并增加了复发-缓解型多发性硬化症中无疾病活动证据的患者比例:ADVANCE随机对照试验的2年结果
机译:关于在随机对照试验中使用移动感应预测精神分裂症的复发
机译:多发性硬化症的处理速度和工作记忆训练:一项双盲随机对照试验。
机译:阿托伐他汀被添加到干扰素β中以复发多发性硬化:一项随机对照试验
机译:阿托伐他汀被添加到干扰素β中以复发多发性硬化:一项随机对照试验